Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

IDNA ETF Forecast & Price Targets

Compare
See the Price Targets and Ratings of:All AnalystsTop AnalystsPremium

IDNA Analyst Ratings

Moderate Buy
46ConsensusRatings
34Buy10Hold2Sell
Based on the Wall Street analyst consensus for 46 of IDNA’s holdings.

IDNA 12 Month Forecast

$49.98▲(23.30% Upside)
Based on Wall Street analyst 12-month price targets for 46 of iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund’s holdings in the last 3 months. The average price target is $49.98 with a high forecast of $64.54 and a low forecast of $34.96. The average price target represents a 23.30% change from the last price of $40.54.
Highest Price Target$64.54Average Price Target$49.98Lowest Price Target$34.96

IDNA Stocks With Highest Upside Potential

IDNA highest upside
NamePrice & ChangeAnalyst ConsensusAnalyst Price Target
Strong Buy$10.20(1207.69% Upside)
Strong Buy$13.00(470.18% Upside)
Strong Buy$14.57(227.45% Upside)
Strong Buy$29.50(209.87% Upside)
Strong Buy$26.81(195.32% Upside)

IDNA Stocks With Highest Downside Potential

IDNA highest downside
NamePrice & ChangeAnalyst ConsensusAnalyst Price Target
Hold$115.00(-47.25% Downside)
Moderate Sell$8.00(-22.10% Downside)
Hold$53.45(-14.10% Downside)
Moderate Sell¥2,200.00(-8.88% Downside)
Hold$10.75(-4.53% Downside)

IDNA ETF FAQ

What is IDNA’s average 12-month price target, according to analysts?
Based on Wall Street analyst price targets for 46 of IDNA’s holdings, iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund’s 12-month average price target is $49.98.
What is IDNA’s upside potential, based on the analysts’ average price target?
IDNA’s average price target of $49.98 represents a 23.30% upside from its last price of $40.54.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is IDNA a Buy, Sell or Hold?
iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund has a consensus rating of Moderate Buy, based on the analyst consensus for 46 of IDNA’s holdings: 34 rated Buy, 10 rated Hold and 2 rated Sell.
What is iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund’s price target?
The average price target for iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund is $49.98, based on Wall Street analyst 12-month price targets for 46 of IDNA’s holdings, issued in the past 3 months. The highest price target is $64.54 and the lowest is $34.96. The average price target represents a 23.30% increase from the last price of $40.54.
What do analysts say about iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund?
iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund’s analyst rating consensus is Moderate Buy, based on Wall Street analyst ratings for 46 of IDNA’s holdings.
How can I buy shares of IDNA?
You can buy shares of IDNA through a brokerage account. Compare brokers on our Best Online Brokers page.